Development of a fluorogenic small substrate for dipeptidyl peptidase-4

被引：4

作者：

Ogawa, Futa ^{[1
]}

Takeda, Masanori ^{[1
]}

Miyanaga, Kanae ^{[2
]}

Tani, Keita ^{[2
]}

Yamazawa, Ryuji ^{[1
]}

Ito, Kiyoshi ^{[1
]}

Tarui, Atsushi ^{[1
]}

Sato, Kazuyuki ^{[1
]}

Omote, Masaaki ^{[1
]}

机构：

[1] Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan

[2] Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan

来源：

BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY | 2017年 / 13卷

关键词：

dipeptidyl peptidase-4; fluorogenic substrate; fluorometry; small fluorescent molecule; SOLID-STATE; FLUORESCENT-PROBE; IN-VIVO; CELLS; DESIGN; VIOLET; TUMOR; IV;

D O I：

10.3762/bjoc.13.267

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

A series of aniline and m-phenylenediamine derivatives with electron-withdrawing 3,3,3-trifluoropropenyl substituents were synthesized as small and chemically stable fluorescent organic compounds. Their fluorescence performances were evaluated by converting 2,4-disubstituted aniline 1 to the non-fluorescent dipeptide analogue H-Gly-Pro-1 for the use as a fluorogenic substrate for dipeptidyl peptidase-4 (DPP-4). The progress of the enzymatic hydrolysis of H-Gly-Pro-1 with DPP-4 was monitored by fluorometric determination of 1 released into the reaction medium. The results suggest that 1 could be used as fluorophore in OFF-ON-type fluorogenic probes.

引用

页码：2690 / 2697

页数：8

共 50 条

[1] Development of a dual fluorogenic and chromogenic dipeptidyl peptidase IV substrate
Ho, NH
Weissleder, R
Tung, CH
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2599 - 2602
[2] Development of a Novel Vaccine Against Dipeptidyl Peptidase-4 in Mice
Pang, Zhengda
CIRCULATION, 2014, 130
[3] Dipeptidyl peptidase-4 inhibitor approaches
Bloomgarden, Zachary
JOURNAL OF DIABETES, 2017, 9 (01) : 5 - 7
[4] Dipeptidyl peptidase-4 inhibitors and osteoporosis
Lee, Wen-Ling
Lee, Fa-Kung
Wang, Peng-Hui
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 889 - 890
[5] The role of dipeptidyl peptidase-4 inhibitors
Lasserson, Daniel
Mant, Jonathan
BRITISH MEDICAL JOURNAL, 2012, 344
[6] Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits
Yamamoto, Toshihiko
Shimano, Masayuki
Inden, Yasuya
Takefuji, Mikito
Yanagisawa, Satoshi
Yoshida, Naoki
Tsuji, Yukiomi
Hirai, Makoto
Murohara, Toyoaki
HEART RHYTHM, 2015, 12 (06) : 1362 - 1369
[7] The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Kanasaki, Keizo
CLINICAL SCIENCE, 2018, 132 (04) : 489 - 507
[8] The role of Dipeptidyl Peptidase-4 in cutaneous disease
Patel, Payal M.
Jones, Virginia A.
Kridin, Khalaf
Amber, Kyle T.
EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : 304 - 318
[9] Renal outcomes with dipeptidyl peptidase-4 inhibitors
Scheen, A. J.
Delanaye, P.
DIABETES & METABOLISM, 2018, 44 (02) : 101 - 111
[10] Heart failure and dipeptidyl peptidase-4 inhibitors
Krum, Henry
Skiba, Marina
Wu, Shiying
Hopper, Ingrid
EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (06) : 603 - 607

← 1 2 3 4 5 →